Target intelligence / Profile preview

Influenza A virus hemagglutinin protein (H5)

Molecular classification
Viral surface glycoprotein, Hemagglutinin, Fusion protein
01

Overview

The hemagglutinin (HA) protein is a major surface glycoprotein of the influenza A virus, responsible for both binding to host cell receptors and mediating membrane fusion during viral entry. The H5 subtype of HA is notably associated with highly pathogenic avian influenza viruses, such as H5N1, which can infect both birds and humans. HA binds to sialic acid-containing receptors on host cell surfaces via its globular head domain, mainly through HA1. After endocytosis and exposure to acidic pH in endosomes, it undergoes conformational changes that expose the fusion peptide in HA2, enabling membrane fusion and release of viral ribonucleoproteins into the cytoplasm. It is a major target for neutralizing antibodies; and is also targeted by macrocyclic peptides.

Other names
H5 hemagglutininHA (H5 subtype)H5N1 hemagglutinin
02

Mechanism of action

Neutralizing antibodies bind to the receptor-binding site, stem region, or other vulnerable sites preventing viral entry. Macrocyclic peptides bind to conserved regions within the stem domain, inhibiting membrane fusion.

03

Biological functions

Host cell attachmentMembrane fusionViral entryReceptor binding
04

Disease associations

InfectionInfluenzaAvian influenzaZoonotic disease
05

Safety considerations

Potential for antigenic drift and shift leading to reduced vaccine efficacyRisk of zoonotic transmission and pandemic potential
06

Interacting drugs

Neutralizing antibodies

1 more in the full profile.

Beyond the preview

Go deeper on Influenza A virus hemagglutinin protein (H5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin protein (H5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call